| 1 |
Stranzl H,Mayer R,Ofher P,et al.Extracapsular extension in positive axillary lymph nodes in female breast cancer patients.Patterns of failure and indications for postoperative locoregional irradiation.Strahlenther Onkol,2004,180(1):31-37.
|
| 2 |
任庆兰,吴永忠,陈晓品.循证医学与个体化治疗原则指导下的肿瘤学教学.现代医药卫生,2009,25(1):146-148.
|
| 3 |
Cleator S,Ashworth A.Molecular profiling of breast cancer clinical implications.British Journal of Cancer,2004,90(6):1120-1124.
|
| 4 |
曾益新,邵建永,肿瘤的分子分型与分子靶向治疗.中国医药生物技术,2008,3(1):6-7.
|
| 5 |
Weigelt B,Horlings HM,Kreike B,et al..Refinement of breast cancer classification by molecular characterization of histological special types.J Pathol 2008,216(2):141-150.
|
| 6 |
Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science,1987,235(4785):177-182.
|
| 7 |
Li YM,Pan Y,Wei Y,et al.Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.Cancer Cell,2004,6(5):459-469.
|
| 8 |
Pritchard KI, Shepherd LE, O'Malley FP, et al. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med, 2006, 354(20):2103-2111.
|
| 9 |
Goldhirsch A,Wood WC,Gelber RD,et al.Progress and promise:highlights of the international expert consensus on the primary therapy of early breast cancer 2007.Ann Oncol,2007,18(7):1133-1144.
|
| 10 |
府伟,黄庆.肿瘤个体化治疗.重庆医学,2008,37(3):225-226.
|
| 11 |
Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor positive breast cancer. J Clin Oncol,2006,24(23):3726-3734.
|
| 12 |
Cronin M, Sangli C, Liu ML, et al. Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative,estrogen receptor-positive breast cancer.Clin Chem,2007,53(6):1084-1091.
|
| 13 |
江泽飞,王涛.2008 年NCCN 乳腺癌临床实践指南（中国版）解读.中华外科杂志,2009,47(7):485-487.
|